Neurocrine Biosciences, Inc. (BVMF:N1BI34)

Neurocrine Biosciences Statistics

Total Valuation

BVMF:N1BI34 has a market cap or net worth of BRL 77.54 billion. The enterprise value is 74.18 billion.

Market Cap	77.54B
Enterprise Value	74.18B

Important Dates

The next estimated earnings date is Monday, February 9, 2026.

Earnings Date	Feb 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.30%
Shares Change (QoQ)	+1.49%
Owned by Insiders (%)	1.09%
Owned by Institutions (%)	101.48%
Float	98.53M

Valuation Ratios

The trailing PE ratio is 33.99 and the forward PE ratio is 15.34.

PE Ratio	33.99
Forward PE	15.34
PS Ratio	5.42
PB Ratio	4.84
P/TBV Ratio	4.90
P/FCF Ratio	24.53
P/OCF Ratio	22.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.18, with an EV/FCF ratio of 23.47.

EV / Earnings	32.52
EV / Sales	5.22
EV / EBITDA	22.18
EV / EBIT	25.92
EV / FCF	23.47

Financial Position

The company has a current ratio of 3.38, with a Debt / Equity ratio of 0.16.

Current Ratio	3.38
Quick Ratio	2.89
Debt / Equity	0.16
Debt / EBITDA	0.76
Debt / FCF	0.81
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 14.96% and return on invested capital (ROIC) is 10.41%.

Return on Equity (ROE)	14.96%
Return on Assets (ROA)	8.66%
Return on Invested Capital (ROIC)	10.41%
Return on Capital Employed (ROCE)	14.89%
Revenue Per Employee	7.94M
Profits Per Employee	1.27M
Employee Count	1,800
Asset Turnover	0.69
Inventory Turnover	17.15

Taxes

In the past 12 months, BVMF:N1BI34 has paid 1.07 billion in taxes.

Income Tax	1.07B
Effective Tax Rate	31.91%

Stock Price Statistics

The stock price has increased by +9.74% in the last 52 weeks. The beta is 0.28, so BVMF:N1BI34's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+9.74%
50-Day Moving Average	37.86
200-Day Moving Average	36.21
Relative Strength Index (RSI)	54.33
Average Volume (20 Days)	633

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.55

Income Statement

In the last 12 months, BVMF:N1BI34 had revenue of BRL 14.30 billion and earned 2.28 billion in profits. Earnings per share was 22.34.

Revenue	14.30B
Gross Profit	9.04B
Operating Income	2.88B
Pretax Income	3.35B
Net Income	2.28B
EBITDA	3.04B
EBIT	2.88B
Earnings Per Share (EPS)	22.34

Balance Sheet

The company has 5.94 billion in cash and 2.56 billion in debt, giving a net cash position of 3.38 billion.

Cash & Cash Equivalents	5.94B
Total Debt	2.56B
Net Cash	3.38B
Net Cash Per Share	n/a
Equity (Book Value)	16.01B
Book Value Per Share	160.56
Working Capital	8.10B

Cash Flow

In the last 12 months, operating cash flow was 3.39 billion and capital expenditures -232.89 million, giving a free cash flow of 3.16 billion.

Operating Cash Flow	3.39B
Capital Expenditures	-232.89M
Free Cash Flow	3.16B
FCF Per Share	n/a

Margins

Gross margin is 63.21%, with operating and profit margins of 20.14% and 15.95%.

Gross Margin	63.21%
Operating Margin	20.14%
Pretax Margin	23.43%
Profit Margin	15.95%
EBITDA Margin	21.25%
EBIT Margin	20.14%
FCF Margin	22.11%

Dividends & Yields

BVMF:N1BI34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.30%
Shareholder Yield	1.30%
Earnings Yield	2.94%
FCF Yield	4.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:N1BI34 has an Altman Z-Score of 7.52 and a Piotroski F-Score of 4.

Altman Z-Score	7.52
Piotroski F-Score	4